Estudios
I+D+I
Institución
Internacional
Vida Universitaria
Universidad de Zaragoza Repository
Search
Submit
Personalize
Your alerts
Your baskets
Your searches
Help
EN
/
ES
Home
>
Articles
>
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study
> Access to Fulltext
Usage statistics
Plots
Efficacy and Safety of Alirocumab 150 mg Every 4 Weeks in Patients With Hypercholesterolemia Not on Statin Therapy: The ODYSSEY CHOICE II Study
-
Stroes, E.
et al
- ART-2016-106055
Main
file(s):
texto_completo
version 1
texto_completo.jpg (icon)
[112.67 KB]
22 May 2018, 13:37
Versión publicada
texto_completo.pdf
[1.02 MB]
22 May 2018, 13:37
Versión publicada